Skip to content

Brown Adipose Tissue in Type 1 Diabetes

Studies of Activity of Brown Adipose Tissue With Positron Emission Tomography Using the Tracer 18F-deoxy Glucose in Patients With Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02984514
Enrollment
11
Registered
2016-12-07
Start date
2015-10-31
Completion date
2018-06-30
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type1diabetes

Brief summary

Brown adipose tissue has the capacity to consume large amounts of energy and has insulin-independent glucose uptake. The investigators have recently observed an inverse correlation between irisin levels and insulin needs of type 1 diabetes patients. Transplantation of brown adipose tissue to insulin-deficient rats normalized their blood glucose levels. In this study 12 patients with long-standing type 1 diabetes (\>10 years) and with variable exogenous insulin needs will be investigated for amount of brown adipose tissue with positron emission tomography using the tracer 18F-deoxy glucose.

Interventions

RADIATIONPositron emission tomography with tracer 18F-deoxy glucose

Assessment of activity of brown adipose tissue with positron emission tomography using the tracer 18F-deoxy glucose

Sponsors

Per-Ola Carlsson
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients (18 years of age or more) 2. Type 1 diabetes diagnose for more than 10 years

Exclusion criteria

1. Ongoing pregnancy 2. Ongoing breast-feeding 3. BMI\<19 4. BMI \>30 5. P-creatinine \<110 µmol/l

Design outcomes

Primary

MeasureTime frame
Activity of brown adipose tissue in correlation to exogenous insulin needs using the tracer 18F-deoxy glucose in positron emission tomography measurementsAssessment performed after more than 10 years of diagnosed type 1 diabetes

Secondary

MeasureTime frame
Glucose uptake in muscle in correlation to exogenous insulin needs; assessment using the tracer 18F deoxy glucose in positron emission tomography measurements.Assessment performed after more than 10 years of diagnosed type 1 diabetes

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026